1. Home
  2. ITP vs ONCO Comparison

ITP vs ONCO Comparison

Compare ITP & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IT Tech Packaging Inc.

ITP

IT Tech Packaging Inc.

HOLD

Current Price

$0.15

Market Cap

3.1M

ML Signal

HOLD

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$0.66

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITP
ONCO
Founded
1996
2018
Country
China
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
2.8M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ITP
ONCO
Price
$0.15
$0.66
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
216.2K
183.7K
Earning Date
05-12-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
1.01
22.80
EPS
N/A
N/A
Revenue
$75,837,943.00
$815,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.09
52 Week High
$0.39
$6.73

Technical Indicators

Market Signals
Indicator
ITP
ONCO
Relative Strength Index (RSI) 38.26 36.66
Support Level N/A $0.57
Resistance Level $0.20 $1.01
Average True Range (ATR) 0.01 0.05
MACD -0.00 -0.01
Stochastic Oscillator 0.00 15.94

Price Performance

Historical Comparison
ITP
ONCO

About ITP IT Tech Packaging Inc.

IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Share on Social Networks: